Dianthus Therapeutics (DNTH) Return on Sales: 2023-2025
Historic Return on Sales for Dianthus Therapeutics (DNTH) over the last 3 years, with Sep 2025 value amounting to -40.76%.
- Dianthus Therapeutics' Return on Sales fell 2819.00% to -40.76% in Q3 2025 from the same period last year, while for Sep 2025 it was -40.76%, marking a year-over-year decrease of 2819.00%. This contributed to the annual value of -13.55% for FY2024, which is 181.00% up from last year.
- Dianthus Therapeutics' Return on Sales amounted to -40.76% in Q3 2025, which was down 73.12% from -23.55% recorded in Q2 2025.
- Over the past 5 years, Dianthus Therapeutics' Return on Sales peaked at -9.37% during Q2 2023, and registered a low of -40.76% during Q3 2025.
- In the last 3 years, Dianthus Therapeutics' Return on Sales had a median value of -14.51% in 2024 and averaged -17.16%.
- Per our database at Business Quant, Dianthus Therapeutics' Return on Sales spiked by 168bps in 2024 and then crashed by 2,819bps in 2025.
- Quarterly analysis of 3 years shows Dianthus Therapeutics' Return on Sales stood at -15.23% in 2023, then spiked by 168bps to -13.55% in 2024, then slumped by 2,819bps to -40.76% in 2025.
- Its Return on Sales stands at -40.76% for Q3 2025, versus -23.55% for Q2 2025 and -15.37% for Q1 2025.